Patent challenges in pharmaceuticals / produced by Bloomberg.
Bob Rice, general managing partner with Tangent Capital Partners LLC, looks at Actavis, said to be in early-stage talks to buy Warner Chilcott. He speaks on Bloomberg Television's 'Money Moves.'
Saved in: